Characterisation of adriamycin- and amsacrine-resistant human leukaemic T cell lines
1991

Study of Drug Resistance in Human Leukaemic T Cell Lines

publication Evidence: moderate

Author Information

Author(s): K. Snow, W. Judd

Primary Institution: University of Auckland

Hypothesis

The study aims to elucidate the mechanisms of resistance to adriamycin and amsacrine in human leukaemic T cell lines.

Conclusion

The resistant Jurkat sublines did not exhibit the typical multidrug resistance phenotype, suggesting alternative mechanisms of drug resistance.

Supporting Evidence

  • Resistant Jurkat sublines showed altered drug metabolism compared to parental sublines.
  • Drug accumulation and retention were similar in resistant and control cells.
  • Resistance was not mediated by increased drug efflux or Pgp overexpression.

Takeaway

Some cancer cells can become resistant to drugs used to treat them, and this study looked at how certain T cells resist two specific cancer drugs.

Methodology

The study involved developing drug-resistant sublines of Jurkat T cells and comparing their properties to parental control sublines.

Limitations

The study does not provide a comprehensive analysis of all potential mechanisms of drug resistance.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication